Allogene TherapeuticsALLO
那斯達克 · USD
1.95
-0.04
(-2.02%)
盤中 09/03 12:22 (UTC+8)
09/03 12:22 (UTC+8)
Allogene TherapeuticsALLO
1.95
-0.04
(-2.02%)
財務數據
損益表
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- 0.05
- 4.76
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 4,640 | - | - | - | - | - | - | - | - | 22 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 4,640 | - | - | - | - | - | - | - | - | 22 |
營業費用 | 51,560 | 46,092 | 42,404 | 44,901 | 56,819 | - | 60,490 | - | 71,431 | 69,526 |
研發費用 | 30,721 | 32,003 | 28,632 | 31,164 | 40,156 | 50,200 | 44,972 | 44,713 | 50,355 | 52,259 |
推銷及管理費用 | 20,839 | 14,089 | 13,772 | 13,737 | 14,281 | 14,991 | 15,518 | 16,333 | 16,087 | 17,267 |
非經常性項目費用 | - | - | - | - | 2,382 | - | - | 10,728 | 4,989 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -46,920 | -46,092 | -42,404 | -44,901 | -56,819 | -65,191 | -60,490 | -71,774 | -71,431 | -69,504 |
其他收入及費用 | 4,586 | 3,785 | 3,907 | 3,845 | 6,144 | 5,608 | 1,075 | 5,581 | 5,073 | 4,504 |
利息費用 | 343 | 300 | 313 | 344 | 268 | 150 | 81 | 100 | - | - |
稅前純益 | -42,677 | -42,607 | -38,810 | -41,400 | -50,943 | -59,733 | -59,496 | -66,293 | -66,358 | -65,000 |
所得稅 | - | - | - | - | - | - | 443 | - | - | - |
稅後純益 | -42,677 | -42,607 | -38,810 | -41,400 | -50,943 | -59,733 | -59,939 | -66,293 | -66,358 | -65,000 |
基本每股稅後盈餘(元) | -0.13 | -0.18 | -0.17 | -0.19 | -0.23 | -0.28 | -0.28 | -0.32 | -0.35 | -0.38 |
稀釋每股稅後盈餘(元) | -0.12 | -0.18 | -0.17 | -0.19 | -0.23 | -0.28 | -0.28 | -0.31 | -0.35 | -0.38 |
基本平均股數(千股) | 328930.00 | 240290.00 | 226030.00 | 222038.00 | 218929.00 | 215358.00 | 210572.00 | 209188.00 | 190026.00 | 169128.00 |
稀釋平均股數(千股) | 328930.00 | 240290.00 | 226030.00 | 222038.00 | 218929.00 | 215358.00 | 210572.00 | 209188.00 | 190026.00 | 169128.00 |
還原基本每股稅後盈餘(元) | -0.13 | -0.18 | -0.17 | -0.19 | -0.23 | -0.28 | -0.28 | -0.32 | -0.35 | -0.38 |
還原稀釋每股稅後盈餘(元) | -0.12 | -0.18 | -0.17 | -0.19 | -0.23 | -0.28 | -0.28 | -0.31 | -0.35 | -0.38 |
還原基本平均股數(千股) | 328,930 | 240,290 | 226,030 | 222,038 | 218,929 | 215,358 | 210,572 | 209,188 | 190,026 | 169,128 |
還原稀釋平均股數(千股) | 328,930 | 240,290 | 226,030 | 222,038 | 218,929 | 215,358 | 210,572 | 209,188 | 190,026 | 169,128 |
EBITDA(千元) | -41,002 | -40,323 | -36,261 | -38,882 | -48,740 | -57,790 | -57,833 | -64,685 | -64,915 | -64,242 |